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Uric acid or urate, a compound of extremely limit- 
ed solubility produced in vivo by degradation of 
purines from nucleic acids or other endogenous and 
exogenous sources - has long been considered a meta- 
bolic “enfant terrible” of man. Possessing a vestigial 
uricotelic apparatus but lacking the copper-containing 
enzyme uricase which oxidizes urate to water-soluble 
compounds, man teters on the brink of urico-disaster. 
Although elaborate control mechanisms exist to pre- 
vent flooding by urate, when these systems fail for 
genetic or other reasons body urate pools increase and 
there is danger of precipitation in soft tissues, cartilage 
(tophi) and urine (stones). While the major portion 
(60-70%) of the urate disappearing from the urate 
pool is excreted as such in urine, the remainder may 
be converted to CO,, allantoin, allantoic acid, urea, 
and NH, by bacteria of the gastrointestinal tract [ 1 J . 
In addition oxygen uptake studies have revealed that 
urate may be oxidized by Cu++ above pH 10 and by 
the cytochrome oxidase system (Cu++?) at pH 7.9 [2]. 
Hemoproteins in the presence of peroxide causes 
breakdown of urate to allantoin, CO, and alloxanic 
acid [3]. 
We are reporting in vitro urate oxidation mediated 
solely by Cu++ at pH 6.0-8.2. In fig. 1 the fall in ab- 
sorption of a urate solution incubated with Cu++ 
(urate/Cu++ ratio 1:4) is shown. Cu++ also alters the 
shape of the urate absorption spectrum drastically, 
obliterating the second maximum at 237 rnp. H,S 
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Fig. 1. Time course for the effect of Cu’+ on urate absorption. 
Urate = 0.15 pmole, Cu++ = 0.60 @mole, vol = 3.0 ml. pH = 
6.1, T = 24’. Beckman DB scanning time = 3 min. Cu” omit- 
ted = 0 min urate spectrum. 
stops the fall in W absorption caused by Cu++, the 
centrifuged supernatant fluid has the same absorption 
spectrum as urate. When uric acid-6-14C was incubat- 
ed with Cu++ in a closed vessel, labeled CO, was 
evolved. This was also the case when Cu+ and H202 
339 
Volume 2, number 5 FEBS LETTERS March 1969 
Table 1 
Oxiation of uratc-6-t4C 
PIask contents 
CO2 ** 
(cpm X 103) 
mate-6-t4C (control) * 1.6 
uratc-6-t4C * + EDTA 0.2 
mate-6-t4C + Cu+ (CuCI) 74 
mate-6-t4C + CU” (cuS04) 97 
mate-6-t% + Cu’* + EDTA 0.2 
urate-6-t4C + Fc” (FeS04) 0.7 
urate-6-r‘% + Fern (FeC13) 1 
urate-6-t4C + Ha02 77 
urate-6-14C + Ha02 + EDTA 1 
urate-6-t4C + Ha02 + Cu” 279 
uratc-6-t4C + Ha02 + Cu* + EDTA 1 
mate-2-t4C (control) * 6.7 
mate-2-14C * + 01” 6.7 
Urate and metals = 0.095 pmole, EDTA = 0.95 pmole, total 
volume = 3.0 ml, pH = 7.5. Solutions were pipettcd into rub- 
her-capped flasks quipped with a suspended plastic Hyamine 
container [4 J Uratc-t4C was injected through the cap and 
the Basks were shaken at 100 strokes/min at 37’ for 40 min. 
The reaction was stopped by the addition of 0.5 ml of 0.5 N 
HaS0.r and the shaking was continued for an additional 90 
min, which time sufficed to trap 99% of the evolved CO2 in 
the Hyamine. The Hyaminc container was removed, immersed 
in a toluenc phosphor solution and counted in a Packard Tri 
Carb liquid scintillation spcctromcter. 
* 0.25 nc = 5.55 X lo5 cpm. Efficiency of counting was 
87%. Thus 100 X lo3 cpm represented approximately 30% 
of the urate-t4C initially placed into the flask. 
** Radioactive CO2 was slowly evolved from the substrate 
controls (urate-6-t4C or 2-t4C) yielding from several hun- 
dred up to several thousand cpm. Such control counts 
could be lowered when desired by preliminary aeration 
(or bubbling with Na) or by addition of EDTA or Hf to 
pH I-3 and significantly lowered by both treatments. 
Usually these procedures were not necessary; significant 
differences between control and experimental flasks were 
clearly evident. 
were substituted for Cu++. However, EDTA stopped 
the reaction with these oxidizing agents. Fe+++ and 
Fe++ were not active in the oxidation of urate (table 1). 
When uric acid-2-14C was substituted for uric acid-6- 
t4C, no 14C02 above background was released. 
Cu++ has great affinity for anions and amino 
groups. At pH 7 the evolution of radioactive CO, 
Table 2 
Effect of buffers on urate oxidation by Cu++ 
Flask contents CO2 
(cpm X 103) 
urate-6-t4C (control) 2 
urate-6-t4C + Cu’+ 118 
urate-6- 14C + NaHaP04 0.3 
urate-6-t4C + Cu” + NaHaP@ 11 
urate-6-t4C + tris 0.3 
urate-6-*4C + tris + Cu” 7.5 
urate-6-t4C + glycylglycine 0.2 
urate-6-t4C + glycylglycine + Cu” 0.2 
urate-6-W + histidine 1 .5 
urate-6-t4C + histidine + Cu” 1.8 
Buffers = 0.05 M, urate-6-r4C = 0.095 rmole, 0.25 PC, vol- 
ume = 3.0 ml, pH 7.5. Procedure as described in legend of 
table 1. 
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b’ig. 2. Time course for effect of Cu” on urate absorption at 
292 mu, pH 6.0 and 7.0. Urate = 0.185 pmoles, Cu” = 0.185 
wmoles, vol = 3.0 ml, T = 24”. 
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Table 3 0.6 
Effect of pH on Cu* oxidation of urate-6-14C 
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Flask contents 
co2 
(cpm X 103) 
3.5 
1.5 
11.5 
urate-6-t4C (control) 0.2 
mate-6-t4C + Cu+’ 0.8 
urate-6-t4C (control) 1 
mate-6-14C + Cu* 106 
uratc-6-*4C (control) 18 
urate-6-t4C + Cu* 360 
Urate-6-t4C = 0.095 pmole, 0.25 c(c; Cu” = 0.095 rmoles; 
volume = 3.0 ml; pH adjusted with dilute HCl or NaOH. Pro- 
cedure as described in legend of table 1. 
from urate-6-14C by Cu++ was inhibited by phosphate 
and tris and completely inhibited by glycylglycine 
and histidine (table 2). CN- also effectively blocked 
the reaction. Fig. 2 shows the rate of mate oxidation 
by Cu++ measured spectrophotometrically at pH 6.0 
and at 7.0. At pH 5.5 the reaction was very slow, at 
pH 5 no reaction could be detected. Above pH 7 a 
slight haze developed in the Cu++ solution rendering 
it unsuitable for spectrophotometry. Results obtained 
with urate-6-14C confirmed the diminished Cu++ oxi- 
dation rate at low pH and the accelerated rate at high 
pH (table 3). Fig. 3 shows the extent of recovery of 
urate after zero, three and nine hours reaction with 
cu++. Chromatograms containing the products of 
urate with Cu++ were sprayed separately with di- 
methylaminobenzaldehyde (Erlich’s reagent) and 
diphenylcarbazone. A reactive spot with the same 
mobility and color as allantoin with both reagents 
was observed on the chromatograms. 
Cu++ tightly bound in uricase does not act as a 
reversible redox system. Mahler et al. have suggested 
that urate oxidation occurs within a ternary complex 
of substrate, enzyme and acceptor [S] . The role of 
Cu++ is to chelate and bring into proximity urate and 
O,, to allow interpenetration of metal and ligand or- 
bitals and to polarize the electrons to be transferred. 
After electron transfer the reaction to allantoin in- 
volving decarboxylation and ring rearrangement pro- 
ceeds non-enzymatically. In contrast to its role in 
uricase, Cu++ alone may non-enzymatically oxidize 
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Fig. 3. Ultraviolet absorption spectrum of H2S treated uratc 
+ Cu* solutions at 0, 3 and 9 hours. 1.2 rmoles urate was 
incubated with 1.2 r.rmoles Cu”, pH = 7.0, 37’, vol = 5 ml. 
After gassing with H2S and centrifuging, 1 .O ml aliquots of 
the supernatant fluid were chromatographed (descending) on 
Whatman No. 1 paper with Hz0 as solvent. The single UV- 
absorbing spot was cluted with 0.001 M NaHCOa for 16 hours 
at 4O and scanned from 200 to 360 nip with a Beckman 
model DB recording spectrophotometer. 
urate directly to CO, and allantoin at body pH. This 
may be a mechanism for degradation of urate in orga- 
nisms lacking uricase. 
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